141 related articles for article (PubMed ID: 31668633)
1. Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.
Hu R; Gupta R; Wang Z; Wang C; Sun H; Singamaneni S; Kharasch ED; Morrissey JJ
Kidney Int; 2019 Dec; 96(6):1417-1421. PubMed ID: 31668633
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
3. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
4. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
Morrissey JJ; Kharasch ED
J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
[TBL] [Abstract][Full Text] [Related]
5. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED
Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027
[TBL] [Abstract][Full Text] [Related]
6. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?
Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS
Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901
[TBL] [Abstract][Full Text] [Related]
7. Urinary biomarkers for the early diagnosis of kidney cancer.
Morrissey JJ; London AN; Luo J; Kharasch ED
Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178
[TBL] [Abstract][Full Text] [Related]
8. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
[TBL] [Abstract][Full Text] [Related]
9. An impedimetric biosensor for the diagnosis of renal cell carcinoma based on the interaction between 3-aminophenyl boronic acid and sialic acid.
Zhang L; Yu C; Gao R; Niu Y; Li Y; Chen J; He J
Biosens Bioelectron; 2017 Jun; 92():434-441. PubMed ID: 27839731
[TBL] [Abstract][Full Text] [Related]
10. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
Morrissey JJ; London AN; Lambert MC; Kharasch ED
Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
[TBL] [Abstract][Full Text] [Related]
12. Prognostic urinary miRNAs for the assessment of small renal masses.
Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
[TBL] [Abstract][Full Text] [Related]
13. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
15. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?
Grebe SK; Erickson LA
Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833
[No Abstract] [Full Text] [Related]
16. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
Dis Markers; 2014; 2014():135649. PubMed ID: 24803718
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.
Zhang KJ; Wilson GD; Kara S; Majeske A; Zhang PL; Hafron JM
Int Urol Nephrol; 2019 Nov; 51(11):1893-1902. PubMed ID: 31385177
[TBL] [Abstract][Full Text] [Related]
19. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
[TBL] [Abstract][Full Text] [Related]
20. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
Tolkach Y; Lüders C; Meller S; Jung K; Stephan C; Kristiansen G
Oncotarget; 2017 Apr; 8(17):28672-28682. PubMed ID: 28404922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
